Biological & pharmaceutical bulletinHumansAnalgesicsOpioidMaleImmune Checkpoint Inhibitors
A Multicenter Retrospective Observational Study on Drug-Drug Interactions between Opioid Analgesics and Immune Checkpoint Inhibitors in Cancer Patients.
Akime Miyasato, Noriaki Hidaka, Miyui Funato, Kazuyo Nakamura, Ryusuke Ouchi, Kensaku Awaji, Takahiko Aoyama, Hideya Kokubun
Published: 202510.1248/bpb.b25-00515
Abstract
Opioid analgesics are indispensable therapeutic agents for patients experiencing cancer pain. Recently, immune checkpoint inhibitors (ICIs) have made substantial progress in cancer treatment, and the range of cancer types for which they are applicabl…
Preview only. Read the full abstract at the source